Skip to content

Advertisement

Open Peer Review Reports for: Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
30 Nov 2016 Submitted Original manuscript
7 Dec 2016 Author responded Author comments - Eva van Doorn
Resubmission - Version 2
7 Dec 2016 Submitted Manuscript version 2
28 Feb 2017 Reviewed Reviewer Report - Victor Huber
8 Mar 2017 Reviewed Reviewer Report - Karl Albert Brokstad
21 Mar 2017 Author responded Author comments - Eva van Doorn
Resubmission - Version 3
21 Mar 2017 Submitted Manuscript version 3
Publishing
24 Mar 2017 Editorially accepted
4 Apr 2017 Article published 10.1186/s12879-017-2341-9

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement